Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cyclin-dependent kinase 9 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | cyclin-dependent kinase 9 | 372 aa | 313 aa | 31.6 % |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 28 % | Viability of K562 cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 28 % | Viability of K562 cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 44 % | Viability of MCF7 cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 44 % | Viability of MCF7 cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 69 % | Viability of G361 cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 69 % | Viability of G361 cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 95 % | Viability of HOS cells at 100 uM | ChEMBL. | 17064068 |
Activity (functional) | = 95 % | Viability of HOS cells at 100 uM | ChEMBL. | 17064068 |
IC50 (binding) | = 12.4 uM | Inhibition of CDK9/Cyclin T1 in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | = 12.4 uM | Inhibition of CDK9/Cyclin T1 in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | = 23 uM | Inhibition of CDK2/Cyclin E in presence of 15 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | = 23 uM | Inhibition of CDK2/Cyclin E in presence of 15 uM ATP | ChEMBL. | 17064068 |
IC50 (functional) | = 65 uM | Antiproliferative activity against MCF7 cell line | ChEMBL. | 17064068 |
IC50 (functional) | = 65 uM | Antiproliferative activity against MCF7 cell line | ChEMBL. | 17064068 |
IC50 (binding) | = 68 uM | Inhibition of CDK2/Cyclin E in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | = 68 uM | Inhibition of CDK2/Cyclin E in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | = 70 uM | Inhibition of CDK4/Cyclin D1 in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | = 70 uM | Inhibition of CDK4/Cyclin D1 in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (functional) | = 79 uM | Antiproliferative activity against K562 cell line | ChEMBL. | 17064068 |
IC50 (functional) | = 79 uM | Antiproliferative activity against K562 cell line | ChEMBL. | 17064068 |
IC50 (functional) | > 100 uM | Antiproliferative activity against HOS cell line | ChEMBL. | 17064068 |
IC50 (functional) | > 100 uM | Antiproliferative activity against G361 cell line | ChEMBL. | 17064068 |
IC50 (binding) | > 100 uM | Inhibition of CDK1/Cyclin B in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | > 100 uM | Inhibition of CDK2/Cyclin A in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | > 100 uM | Inhibition of CDK7/Cyclin H in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | > 100 uM | Inhibition of CDK1/Cyclin B in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | > 100 uM | Inhibition of CDK2/Cyclin A in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (binding) | > 100 uM | Inhibition of CDK7/Cyclin H in presence of 100 uM ATP | ChEMBL. | 17064068 |
IC50 (functional) | > 100 uM | Antiproliferative activity against HOS cell line | ChEMBL. | 17064068 |
IC50 (functional) | > 100 uM | Antiproliferative activity against G361 cell line | ChEMBL. | 17064068 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.